Tech Atlas Group is the research-focused division of RA Capital, a Boston-based investment firm. They analyze scientific and clinical data to provide context and understanding in a world flooded with data, helping to identify breakthroughs and originate conviction in new ideas. Tech Atlas works closely with RA Capital's Investment Team and portfolio companies to anticipate how breakthroughs might impact industry stakeholders, physicians, patients, and policymakers, and their work is captured in a collection of competitive landscapes or maps that identify competitive drugs, diagnostics, and technological capabilities in various areas.
Through their analysis, Tech Atlas helps guide internal investment decisions and also shares their maps with collaborators and portfolio companies to inform clinical development or strategic decisions and partnerships. They aim to define companies by the problem they aim to solve and select appropriate technologies based on the unique etiology and pathophysiology of relevant diseases. Their work also helps companies understand what technologies they can license to tailor their development towards the most competitive target product profile. Tech Atlas is always seeking smart, intellectually curious, and driven scientists to join their team and make sense of data-rich landscapes across therapeutics, diagnostics, and devices while incorporating business strategy into their thinking.
Generated from the website